Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas

Introduction: For patients with localized node-negative (Stage I and II) clear cell renal cell carcinomas (ccRCC), current clinicopathological staging has limited predictive capability because of their low risk. Analyzing molecular signatures at the time of nephrectomy can aid in understanding futur...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Andrew J., Murphy, Neal, Kozel, Zachary, Shah, Paras, Yaskiv, Oksana, Khalili, Houman, Liew, Anthony, Kavoussi, Louis, Hall, Simon, Vira, Manish, Zhu, Xin-Hua, Lee, Annette T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431518/
https://www.ncbi.nlm.nih.gov/pubmed/32850445
http://dx.doi.org/10.3389/fonc.2020.01383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431518/
https://www.ncbi.nlm.nih.gov/pubmed/32850445
http://dx.doi.org/10.3389/fonc.2020.01383

Ejemplares similares